Additionally, while our study controlled for age and APOE ε4 status, other potential confounding factors such as hypertension, diabetes, and small vessel disease were not accounted for, which may influence CMH occurrence and cognitive impairment. The gene discussed is APOE; the disease is hypertrophic cardiomyopathy 1.